Bette Korber | Laboratory Fellow Los Alamos National Laboratory
April 14 Pre-congress Workshop Day @ 10:00
HALF DAY WORKSHOP A1: VACCINE TECHNOLOGY
New emerging tools in immunology have become a much-anticipated field over the years with increasingly more preclinical and clinical staged developments. This workshop focuses on recent advances and their application in providing protection against infectious diseases to improve immunogenicity of vaccines and understanding the immune response.
HIV Adaptive Immunity
What have we learned from the adaptive immunity response to better our knowledge of HIV and vaccine design
Understanding the immune response during disease and vaccinology
Systems Biology in vaccinology
How is this being integrated for rational vaccine designs
Computational and Bioinformatics tools
Applications to vaccines development and clinical efficacy
Jason Mclellan / HALF DAY WORKSHOP A1: VACCINE TECHNOLOGY
Jason Mclellan, Assistant Professor, Geisel School of Medicine
Jason earned a BS in chemistry with an emphasis in biochemistry from Wayne State University in Detroit, Michigan. Afterward, he obtained his PhD from the Johns Hopkins University School of Medicine in Baltimore, Maryland in the laboratory of Dr Daniel Leahy. He then carried out postdoctoral...
Harry Kleanthous / HALF DAY WORKSHOP A1: VACCINE TECHNOLOGY
Harry Kleanthous, Associate Vice President, Head Of Research, North America, Sanofi Pasteur
Dr. Kleanthous has over 20 years industry experience in the research & development of recombinant live attenuated and subunit-based vaccines against viral and bacterial pathogens.
He joined Sanofi Pasteur as US Head of Discovery Research in 2008 with responsibility for evaluating and...
Steven Bosinger / HALF DAY WORKSHOP A1: VACCINE TECHNOLOGY
Steven Bosinger, Assistant Professor, Emory School of Medicine
Dr. Bosinger received his PhD from the University of Western Ontario in Microbiology & Immunology and has focused on studying the pathogenic events in early HIV and SIV infection. He completed a post-doctoral fellowship at the University of Pennsylvania from 2008-2010. In 2010 he moved to...
Rino Rappuoli / HALF DAY WORKSHOP A1: VACCINE TECHNOLOGY
Rino Rappuoli, Chief Scientist, GSK Vaccines
Dr Rino Rappuoli is currently serves as Chief Scientist at GSK vaccines (previously Novartis Vaccines in Siena, Italy, where his former role was the Global Head of Vaccines Research). Prior to this he was Head of R&D for Sclavo and then Head of Vaccine Research and Chief Scientific Officer for...
Galit Alter / HALF DAY WORKSHOP A1: VACCINE TECHNOLOGY
Galit Alter, Associate Professor Of Medicine, Harvard Medical School
Galit Alter received her PhD in experimental medicine from McGill University, and is currently an Associate Professor in Medicine at Harvard Medical School. Over the past 8 years her research has focused on understanding the role of the innate immune response to chronic viral infections, including...